Researchers at the University of New South Wales Sydney have developed a fully synthetic soft robotic heart capable of replicating the complex internal structures and dynamic contractions of the human left heart. Published recently in Nature Communications and Advanced Science, the innovation establishes a controllable physiological platform for cardiovascular research, medical device testing, and personalized treatment planning. The device integrates silicone membranes forming the inner chambers with soft robotic artificial muscles that replicate the layered contraction and twisting mechanics of natural cardiac tissue. Hydraulic pressure drives these synthetic fibers, enabling precise simulation of critical anatomical features including the mitral valve, papillary muscles, and chordae tendineae. By adjusting tension in the artificial musculature, the team successfully reproduced pathological conditions such as mitral valve prolapse and regurgitation, where blood leaks backward into the atrium. Ultrasound imaging and invasive pressure measurements confirmed that the model generates human-like flow waveforms and valve leaflet motion, accurately mirroring both healthy function and disease progression. The platform primary advantage lies in its capacity to simulate complex cardiovascular conditions, particularly heart failure with preserved ejection fraction, which accounts for half of all heart failure cases and remains poorly understood mechanistically. By replicating delayed ventricular relaxation and subsequent pressure buildup, the robotic heart provides a controlled environment to investigate disease mechanics without relying on living subjects. This capability significantly reduces the ethical and financial burdens associated with traditional animal testing during early stage biomedical research. Additionally, the team demonstrated the system utility in evaluating emerging surgical technologies, successfully navigating a soft robotic cardiac catheter within the beating model to map contact with dynamic cardiac structures. Beyond laboratory research, the technology holds promise for advancing personalized cardiology. Researchers envision generating patient specific models derived from clinical imaging data to evaluate implant geometries, test surgical approaches, and optimize treatment parameters prior to intervention. Scientia Associate Professor Thanh Nho Do, who led the project, emphasized that the platform bridges the gap between static benchtop simulators and living systems, offering anatomical fidelity with experimental control. The research team includes UNSW experts in biomedical engineering and clinical cardiology from St Vincent Hospital Sydney, reflecting a multidisciplinary approach to cardiovascular innovation. While the current prototype serves as a proof of concept, the researchers acknowledge several developmental hurdles before clinical deployment. Future iterations will require enhanced material durability, refined hydraulic control systems, and deeper compatibility with medical imaging modalities. The team immediate priority involves systematic validation against extensive clinical datasets across diverse cardiac pathologies and anatomical variations. As soft robotics continues to converge with biomedical engineering, this adaptable simulation platform is positioned to accelerate the translation of novel cardiac therapies, ultimately improving patient outcomes while streamlining the medical device development pipeline.